ArticleCancer discovery2024

Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti-PD-1 Monotherapy: A Report from the International RRD Consortium.

Anirban Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.